Intermittent pneumatic compression in stable claudicants: Effect on hemostasis and endothelial function

International Angiology

Volumn 28, Issue 5, 2009, Pages 373-379

  Sutkowska, E ^a,b   Wozniewski, M ^a   Gamian, A ^c   Gosk Bierska, I ^b   Alexewicz, P ^b   Sutkowski, K ^a,b   Wysokinski, W E ^a,b,d  

^a JÓZEF PI SUDSKI UNIVERSITY OF PHYSICAL EDUCATION IN WARSAW   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^d MAYO CLINIC   (United States)

Author keywords

Intermittent claudication; Intermittent pneumatic compression devices; Nitric oxide; Platelet factor 4; Von Willebrand factor

Indexed keywords

NITRATE; NITRITE; THROMBIN ANTITHROMBIN COMPLEX; THROMBOCYTE FACTOR 4; VON WILLEBRAND FACTOR; ANTITHROMBIN III; ANTITHROMBIN III-PROTEASE COMPLEX; BIOLOGICAL MARKER; NITRIC ACID DERIVATIVE; PEPTIDE HYDROLASE;

ADULT; AGED; ARTERY DISEASE; ARTICLE; BLOOD CLOTTING; CELL FUNCTION; CLINICAL ARTICLE; COMPRESSION THERAPY; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HEMOSTASIS; HUMAN; INTERMITTENT CLAUDICATION; INTERMITTENT PNEUMATIC COMPRESSION; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; MALE; MAXIMAL WALKING DISTANCE; PAIN FREE WALKING DISTANCE; PARAMETER; SAFETY; STATISTICAL SIGNIFICANCE; THERAPY EFFECT; THROMBOCYTE ACTIVATION; WALKING; BLOOD; CONTROLLED CLINICAL TRIAL; CONVALESCENCE; EXERCISE TOLERANCE; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; POLAND; PROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

ADULT; AGED; ANTITHROMBIN III; BIOLOGICAL MARKERS; BLOOD COAGULATION; ENDOTHELIUM, VASCULAR; EXERCISE TOLERANCE; FEMALE; HEMOSTASIS; HUMANS; INTERMITTENT CLAUDICATION; INTERMITTENT PNEUMATIC COMPRESSION DEVICES; MALE; MIDDLE AGED; NITRATES; NITRITES; PEPTIDE HYDROLASES; PLATELET ACTIVATION; PLATELET FACTOR 4; POLAND; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; TIME FACTORS; TREATMENT OUTCOME; VON WILLEBRAND FACTOR; WALKING;

EID: 77949838438     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Collens WS, Wilensky ND. Intermittent venous occlusion in treatment of peripheral vascular disease. JAMA 1937;109:2125-30.
2. Skillman JJ, Collins REC, Coe NP, Goldstein BS, Shapiro RM, Zervas NT et al. Prevention of deep vein thrombosis in neurosurgical patients: a controlled randomized trial of external pneumatic compression boots. Surgery 1978;83:354-7.
3. Hull RD, Raskob GE, Gent M, McLougblin D, Julian D, Smith FC et al. Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement. JAMA 1990;263:2313-7.
4. Westlich GH, Sculco TP. Prophylaxis against deep venous thrombosis after total knee arthroplasty: pneumatic plantar compression and aspirin compared with aspirin alone. J Bone Joint Surg 1996;78A:826-34.
5. Soderdahl DW, Henderson SR, Hansberry KL. A comparison of intermittent pneumatic compression of the calf and whole leg in preventing deep venous thrombosis in urological surgery. J Urol. 1997;157:1774-6.
6. Handoll HH, Farrar MJ, McBirnie J, Tytherleigh-Strong G, Milne AA, Gillespie WJ. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. Cochrane Database Syst Rev 2002;CD000305.
7. Schuler JJ, Maibenco T, Megerman J, Ware M, Montalvo J. Treatment of chronic venous ulcers using sequential gradient intermittent pneumatic compression. Phlebology 1996;11:111-6.
8. Pappas CJ, O'Donnell Jr TF. Long-term results of compression treatment for lymphedema. J Vasc Surg 1992;16:555-64.
9. Franzeck UK, Spiegel I, Fischer M, Bortzler C, Stahel HU, Bollinger A. Combined physical therapy for lymphedema evaluated by fluorescence microlymphography and lymph capillary pressure measurements. J Vasc Res 1997;34:306-11.
10. Harris SR. Hugi MR. Olivotto IA. Levine M. Steering Committee for Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: Lymphedema CMAJ 2001;164:191-9.
11. Morgan RH, Carolan G, Psaila JV, Gardner AMN, Fox RH, Woodcock JP. Arterial flow enhancement by impulse compression. Vasc Surg 1991;25:8-15.
12. Abu-Own A, Cheatle T, Scurr JH, Coleridge Smith PD. Effects of intermittent pneumatic compression of the foot on the microcirculatory function in arterial disease. Eur J Vasc Surg 1993;7:488-92.
13. van Bemmelen PS, Mattos MA, Faught WE, Mansour MA, Barkmeier LD, Hodgson KJ. Augmentation of blood flow in limbs with occlusive arterial disease by intermittent calf compression. J Vasc Surg 1994;19:1052-8.
14. Eze AR, Comerota AJ, Cisek PL, Comerota AJ Jr, Verramasuneni R, Comerota AJ. Intermittent calf and foot compression increases lower extremity blood flow. Am J Surg 1996;172:130-5.
15. Eze AR, Cisek PL, Holland BS, Comerota Jr AJ, Verramasuneni R, Comerota AJ. The contributions of arterial and venous volumes to increased cutaneous blood flow during leg compression. Ann Vasc Surg 1998;12:182-6.
16. Labropoulos N, Watson WC, Mansour A, Kang SS, Littooy FN, Baker WH. Acute effects of intermittent pneumatic compression on popliteal artery blood flow. Arch Surg 1998;133:1072-5.
17. Delis KT, Nicolaides AN, Wolfe JHN, Stansby G. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up. J Vasc Surg 2000;31:650-61.
18. Montori VM. Kavros SJ. Walsh EE. Rooke TW. Intermittent compression pump for non-healing wounds in patients with limb ischemia. The Mayo Clinic experience (1998-2000). Intern Angiology 2002;21:360-6.
19. Dai G, Tsukurov O, Chen M, Gertler JP, Kamm RD. Endothelial nitric oxide production during in vitro simulation of external limb compression. Am J Physiol Heart Circ Physiol 2002;282:H2066-H2075.
20. Liu K, Chen LE, Seaber AV, Urbaniak JR. Influences of inflation rate and duration on vasodilatory effect by intermittent pneumatic compression in distant skeletal muscle. J Orthop Res 1999;17:415-20.
21. Allenby F, Boardman L, Pflug JJ, Calnan JS. Effects of external pneumatic intermittent compression on fibrinolysis in man. Lancet 1973;2:1412.
22. Tarnay TJ, Rohr PR, Davidson AG, Stevenson MM, Byars EF, Hopkins GR. Pneumatic calf compression, fibrinolysis, and the prevention of deep venous thrombosis. Surgery 1980;88:489-96.
23. Salzman EW, McManama GP, Shapiro AH. Effect of optimization of hemodynamics on fibrinolytic activity and antithrombotic efficacy of external pneumatic compression. Ann Surg 1987;206:636-41.
24. Summaria L, McMillan R, Axelrod CA, Vagher JP, Fareed J. Relationship between postsurgical fibrinolytic parameters and deep vein thrombosis in surgical patients treated with compression devices. Am Surg 1988;54:156-60.
25. Inada K, Koike S, Shirai N, Matsumoto K, Hirose M. Effects of intermittent pneumatic leg compression for prevention of postoperative deep venous thrombosis with special reference to fibrinolytic activity. Am J Surg 1988;165:602-5.
26. Jacob DG, Piotrowski JJ, Hoppensteadt DA, Salvator AE, Fareed J. Hemodynamic and fibrinolytic consequences of intermittent pneumatic compression: preliminary results. J Trauma 1996;40:710-7.
27. Kessler CM, Hirsch DR, Jacobs H, MacDougall R, Goldhaber SZ. Intermittent pneumatic compression in chronic venous insufficiency favorably affects fibrinolytic potential and platelet activation. Blood Coag Fib 1996;7:437-45.
28. Comerota AJ, Chouhan V, Harada RN, Sun L, Hosking J, Veermansunemi R et al. The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Ann Surg 1997;226:306-13.
29. Cahan MA, Hanna DJ, Wiley LA, Cox DK, Killewich LA. External pneumatic compression and fibrinolysis in abdominal surgery. Controlled Clinical Trial. J Vasc Surg 2000;32:537-43.
30. Roslawski A, Dabrowska G. Peripheral vascular disease. Treatment with physical activity. [Organiczne choroby naczyn obwodowych. Leczenie ruchem. In: Roslawski A, Halawa B, Wozniewski M, editors. Rehabilitation therapy in internal medicine. [Rehabilitacja lecznicza w chorobach wewnetrznych. University Medical School of Wroclaw; 1991. p. 42-8.
31. Katz ML, Comerota AJ. Noninvasive evaluation of lower extremity arterial disease. In: Kerstein MD, White JV, editors. Alternatives to open surgery. Philadelphia: Lippincott; 1995. p. 215-24.
32. Amiral J, Adalbert B, Adam M: Application of enzyme immunoassays to coagulation testing. Clin Chem 1984;30:1512-6.
33. Moshage H, Kok B, Huizenga JR, Jansen PL. Nitrite and nitrate determination in plasma: a critical evaluation. Clin Chem 1995;41:892-6.
34. Mannucci PM. von Willebrand factor: a marker of endothelial damage?. Arteriosclerosis, Thrombosis & Vascular Biology. 1998;18:1359-62.
35. van Mourik JA, Romani de Wit T, Voorberg J: Biogenesis and exocytosis of Weibel-Palade bodies. Histochem Cell Biol 2002;117:113-22.
36. Blann AD, Lip GYH, Beevers DG, McCollum CN. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers. Thromb Haemost 1997;78:1077-80.
37. Gresele P, Catalano M, Giammarresi C, Volpato R, Termini R, Ciabattoni G et al. Platelet activation markers in patients with peripheral arterial disease - a prospective comparison of different platelet function tests. Thromb Haemost 1997;78:1434-7.
38. Chouhan VD, Comerota AJ, Sun L, Harada R, Gaughan JP, Rao AK. Inhibition of tissue factor pathway during intermittent pneumatic compression: a possible mechanism for antithrombotic effect. Arterioscler Thromb Vasc Biol 1999;19:2812-7.
39. Moncada, S, Palmer RM, and Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-42.
40. Stamler, J, Mendelsohn ME, Amarante P, Smick D, Andon N, Davies PF et al. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res 1989;65:789-95.
41. Gerlach M, Keh D, Bezold G, Spielmann S, Kurer I, Peter RU et al. Nitric oxide inhibits tissue factor synthesis, expression and activity in human monocytes by prior formation of peroxynitrite. Intensive Care Med 1998;24:1199-208.
42. Yang, Y, Loscalzo J. Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide. Circulation 2000;101:2144-8.
43. Labropoulos, N, Cunningham J, Kang SS, Mansour MA, Baker WH. Optimising the performance of intermittent pneumatic compression devices. Eur J Vasc Endovasc Surg 2000;19:593-7.